Agios Pharmaceuticals (AGIO) News Today $40.87 -0.02 (-0.05%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$40.88 +0.01 (+0.02%) As of 10/7/2025 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AGIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Agios Pharmaceuticals (NASDAQ:AGIO) Share Price Crosses Above 50 Day Moving Average - Here's WhyOctober 7 at 6:27 AM | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Rating of "Moderate Buy" by AnalystsOctober 7 at 2:14 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIOOctober 3, 2025 | prnewswire.comInsider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) CFO Sells 3,651 Shares of StockSeptember 30, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIOSeptember 28, 2025 | prnewswire.comVoya Investment Management LLC Sells 17,760 Shares of Agios Pharmaceuticals, Inc. $AGIOSeptember 28, 2025 | marketbeat.comStrs Ohio Purchases New Shares in Agios Pharmaceuticals, Inc. $AGIOSeptember 25, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIOSeptember 24, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIOSeptember 23, 2025 | prnewswire.comThalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsightSeptember 22, 2025 | uk.finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIOSeptember 18, 2025 | prnewswire.comAGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law FirmSeptember 18, 2025 | prnewswire.comRhumbline Advisers Sells 7,666 Shares of Agios Pharmaceuticals, Inc. $AGIOSeptember 17, 2025 | marketbeat.comBeta Thalassemia Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Ionis Pharmaceuticals, Inc., Agios Pharma, Silence ...September 16, 2025 | theglobeandmail.comAGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law FirmSeptember 15, 2025 | businesswire.comAtavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical OfficerSeptember 15, 2025 | finance.yahoo.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Consensus Rating of "Moderate Buy" by AnalystsSeptember 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIOSeptember 13, 2025 | prnewswire.comAgios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $315,091.02 in StockSeptember 11, 2025 | marketbeat.comSCS Capital Management LLC Makes New $17.91 Million Investment in Agios Pharmaceuticals, Inc. $AGIOSeptember 11, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIOSeptember 10, 2025 | globenewswire.comInsider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells 8,546 Shares of StockSeptember 10, 2025 | insidertrades.comWhat is HC Wainwright's Estimate for AGIO FY2025 Earnings?September 9, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIOSeptember 8, 2025 | prnewswire.comFDA Review Delay for PYRUKYND Might Change the Case for Investing in Agios Pharmaceuticals (AGIO)September 8, 2025 | finance.yahoo.comAgios Pharmaceuticals: Why A Delayed FDA Review Could Still Be A PositiveSeptember 8, 2025 | seekingalpha.comGoldman Sachs Reaffirms Their Hold Rating on Agios Pharma (AGIO)September 8, 2025 | theglobeandmail.comTD Cowen Reaffirms Their Buy Rating on Agios Pharma (AGIO)September 8, 2025 | theglobeandmail.comBank of America Securities Remains a Buy on Agios Pharma (AGIO)September 8, 2025 | theglobeandmail.comGranahan Investment Management LLC Has $3.87 Million Position in Agios Pharmaceuticals, Inc. $AGIOSeptember 7, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Increases Stock Holdings in Agios Pharmaceuticals, Inc. $AGIOSeptember 7, 2025 | marketbeat.comCutter Capital Management LP Has $6.90 Million Stake in Agios Pharmaceuticals, Inc. $AGIOSeptember 6, 2025 | marketbeat.comBoothbay Fund Management LLC Boosts Holdings in Agios Pharmaceuticals, Inc. $AGIOSeptember 6, 2025 | marketbeat.comAgios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out MoreSeptember 5, 2025 | msn.comAgios Pharmaceuticals stock falls after FDA extends review of thalassemia drugSeptember 4, 2025 | za.investing.comAgios Pharmaceuticals falls -13.3%September 4, 2025 | msn.comAgios Pharmaceuticals Shares Fall on FDA Drug Review Extension Over Safety Strategy SubmissionSeptember 4, 2025 | marketwatch.comAgios drops as FDA delays review of thalassemia drugSeptember 4, 2025 | msn.comAgios Pharmaceuticals Shares Drop After FDA Extends Thalassemia Drug ReviewSeptember 4, 2025 | msn.comAgios Pharmaceuticals: New FDA Setback Likely Temporary As Issues Can Be MitigatedSeptember 4, 2025 | seekingalpha.comFDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded UseSeptember 4, 2025 | benzinga.com27,900 Shares in Agios Pharmaceuticals, Inc. $AGIO Purchased by ADAR1 Capital Management LLCSeptember 4, 2025 | marketbeat.comAgios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in ThalassemiaSeptember 4, 2025 | globenewswire.comPalo Alto Investors LP Invests $8.10 Million in Agios Pharmaceuticals, Inc. $AGIOSeptember 4, 2025 | marketbeat.comNorthern Trust Corp Sells 19,222 Shares of Agios Pharmaceuticals, Inc. $AGIOSeptember 4, 2025 | marketbeat.comArmistice Capital LLC Sells 216,304 Shares of Agios Pharmaceuticals, Inc. $AGIOSeptember 2, 2025 | marketbeat.comAmerican Century Companies Inc. Has $3.37 Million Stock Position in Agios Pharmaceuticals, Inc. $AGIOSeptember 2, 2025 | marketbeat.comKodai Capital Management LP Invests $1.49 Million in Agios Pharmaceuticals, Inc. $AGIOSeptember 1, 2025 | marketbeat.comRafferty Asset Management LLC Has $2.74 Million Position in Agios Pharmaceuticals, Inc. $AGIOSeptember 1, 2025 | marketbeat.comInvesco Ltd. Purchases 23,852 Shares of Agios Pharmaceuticals, Inc. $AGIOSeptember 1, 2025 | marketbeat.com Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AGIO Media Mentions By Week AGIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGIO News Sentiment▼0.370.55▲Average Medical News Sentiment AGIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGIO Articles This Week▼37▲AGIO Articles Average Week Get the Latest News and Ratings for AGIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Revolution Medicines News Grifols News Rhythm Pharmaceuticals News Avidity Biosciences News Abivax News Legend Biotech News Cytokinetics News Nuvalent News Axsome Therapeutics News TG Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGIO) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
